SYSTEM AND METHOD FOR SERUM BASED CANCER DETECTION

    公开(公告)号:CA2890437A1

    公开(公告)日:2014-05-15

    申请号:CA2890437

    申请日:2013-11-06

    Abstract: A system and method for analyzing biological samples, such as dried human blood serum, to determine a disease state such as colorectal cancer (CRC). Using dried samples may hold potential for enhancing localized concentration and/or segmentation of sample components. The method may comprise illuminating at least one location of a biological sample to generate a plurality of interacted photons, collecting the interacted photons and generating at least one Raman data set representative of the biological sample. A system may comprise an illumination source to illuminate at least one location of a biological sample and generate at least one plurality of interacted photons, at least one mirror for directing the interacted photons to a detector. The detector may be configured to generate at least one Raman data set representative of the biological sample. The system and method may utilize a FAST device for multipoint analysis or may be configured to analyze a sample using a line scanning configuration.

    SYSTEM AND METHOD FOR SERUM BASED CANCER DETECTION

    公开(公告)号:CA2890437C

    公开(公告)日:2021-02-02

    申请号:CA2890437

    申请日:2013-11-06

    Abstract: A system and method for analyzing biological samples, such as dried human blood serum, to determine a disease state such as colorectal cancer (CRC). Using dried samples may hold potential for enhancing localized concentration and/or segmentation of sample components. The method may comprise illuminating at least one location of a biological sample to generate a plurality of interacted photons, collecting the interacted photons and generating at least one Raman data set representative of the biological sample. A system may comprise an illumination source to illuminate at least one location of a biological sample and generate at least one plurality of interacted photons, at least one mirror for directing the interacted photons to a detector. The detector may be configured to generate at least one Raman data set representative of the biological sample. The system and method may utilize a FAST device for multipoint analysis or may be configured to analyze a sample using a line scanning configuration.

    System and method for serum based cancer detection

    公开(公告)号:AU2013341327A1

    公开(公告)日:2015-07-02

    申请号:AU2013341327

    申请日:2013-11-06

    Abstract: A system and method for analyzing biological samples, such as dried human blood serum, to determine a disease state such as colorectal cancer (CRC). Using dried samples may hold potential for enhancing localized concentration and/or segmentation of sample components. The method may comprise illuminating at least one location of a biological sample to generate a plurality of interacted photons, collecting the interacted photons and generating at least one Raman data set representative of the biological sample. A system may comprise an illumination source to illuminate at least one location of a biological sample and generate at least one plurality of interacted photons, at least one mirror for directing the interacted photons to a detector. The detector may be configured to generate at least one Raman data set representative of the biological sample. The system and method may utilize a FAST device for multipoint analysis or may be configured to analyze a sample using a line scanning configuration.

    CYTOLOGICAL METHODS FOR DETECTING A DISEASE CONDITION SUCH AS MALIGNANCY BY RAMAN SPECTROSCOPIC IMAGING
    9.
    发明申请
    CYTOLOGICAL METHODS FOR DETECTING A DISEASE CONDITION SUCH AS MALIGNANCY BY RAMAN SPECTROSCOPIC IMAGING 审中-公开
    用于通过拉曼光谱成像检测疾病状态如恶性肿瘤的细胞学方法

    公开(公告)号:WO2006135628A2

    公开(公告)日:2006-12-21

    申请号:PCT/US2006/022083

    申请日:2006-06-06

    CPC classification number: G01N21/65 G01N2021/656

    Abstract: Raman molecular imaging (RMI) is used to detect mammalian cells of a particular phenotype. For example the disclosure includes the use of RMI to differentiate between normal and diseased cells or tissues, e.g., cancer cells as well as in determining the grade of said cancer cells. In a preferred embodiment benign and malignant lesions of bladder and other tissues can be distinguished, including epithelial tissues such as lung, prostate, kidney, breast, and colon, and non-epithelial tissues, such as bone marrow and brain. Raman scattering data relevant to the disease state of cells or tissue can be combined with visual image data to produce hybrid images which depict both a magnified view of the cellular structures and information relating to the disease state of the individual cells in the field of view. Also, RMI techniques may be combined with visual image data and validated with other detection methods to produce confirm the matter obtained by RMI.

    Abstract translation: 拉曼分子成像(RMI)用于检测特定表型的哺乳动物细胞。 例如,本公开包括使用RMI来区分正常和患病细胞或组织,例如癌细胞,以及确定所述癌细胞的等级。 在一个优选实施方案中,可以区分膀胱和其他组织的良性和恶性病变,包括上皮组织如肺,前列腺,肾,乳腺和结肠以及非上皮组织,例如骨髓和脑。 可以将与细胞或组织的疾病状态相关的拉曼散射数据与视觉图像数据组合,以产生描绘细胞结构的放大视图和与视野中的各个细胞的疾病状态有关的信息的混合图像。 此外,RMI技术可以与可视图像数据组合,并用其他检测方法验证,以确定RMI获得的事项。

Patent Agency Ranking